GeoVax Labs Investor Relations Material
Latest events
Q2 2025
GeoVax Labs
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from GeoVax Labs Inc
Access all reports
GeoVax Labs Inc is a biotechnology company focused on developing vaccines and immunotherapies for infectious diseases and cancer. The company utilizes its proprietary vaccine platforms to target viral and bacterial pathogens, as well as tumor-associated antigens. Its development pipeline includes both preventive and therapeutic candidates undergoing preclinical and clinical testing. GeoVax Labs Inc is headquartered in Smyrna, Georgia, and its shares are listed on the NASDAQ.
Latest articles
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
Ticker symbol
GOVX
Country
🇺🇸 United States